BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 38746025)

  • 1. Exploring the contrasts: in-depth analysis of human and canine mammary tumors - discoveries at the frontier.
    Gherman LM; Tomuleasa D; Cismaru A; Nutu A; Berindan-Neagoe I
    Med Pharm Rep; 2024 Apr; 97(2):132-142. PubMed ID: 38746025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic signaling pathways and anti-angiogenic therapy for cancer.
    Liu ZL; Chen HH; Zheng LL; Sun LP; Shi L
    Signal Transduct Target Ther; 2023 May; 8(1):198. PubMed ID: 37169756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Endothelial Growth Factor Ligands and Receptors in Breast Cancer.
    Brogowska KK; Zajkowska M; Mroczko B
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity Mechanisms of Blue-Light-Activated Curcumin in T98G Cell Line: Inducing Apoptosis through ROS-Dependent Downregulation of MMP Pathways.
    Alkahtani S; S Al-Johani N; Alarifi S; Afzal M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells.
    Jin K; Qian C; Lin J; Liu B
    Front Oncol; 2023; 13():1099811. PubMed ID: 36776289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors.
    Ramadan ES; Salem NY; Emam IA; AbdElKader NA; Farghali HA; Khattab MS
    Vet Res Commun; 2022 Jun; 46(2):377-388. PubMed ID: 34787777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1.
    Li Y; Hua K; Jin J; Fang L
    Oncol Lett; 2021 Aug; 22(2):580. PubMed ID: 34122631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-21: a non-specific biomarker of all maladies.
    Jenike AE; Halushka MK
    Biomark Res; 2021 Mar; 9(1):18. PubMed ID: 33712063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors.
    Jain M; Ingole SD; Deshmukh RS; Bharucha SV; Nagvekar AS; Gaikwad RV; Kharde SD
    Chromosome Res; 2021 Jun; 29(2):175-188. PubMed ID: 33638118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City.
    Altonen BL; Arreglado TM; Leroux O; Murray-Ramcharan M; Engdahl R
    PLoS One; 2020; 15(12):e0243343. PubMed ID: 33315929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent trends in targeting miRNAs for cancer therapy.
    Shah V; Shah J
    J Pharm Pharmacol; 2020 Dec; 72(12):1732-1749. PubMed ID: 32783235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-497 induces apoptosis by the IRAK2/NF-κB axis in the canine mammary tumour.
    Zhang T; Feng X; Zhou T; Zhou N; Shi X; Zhu X; Qiu J; Deng G; Qiu C
    Vet Comp Oncol; 2021 Mar; 19(1):69-78. PubMed ID: 32706167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-18a activates Wnt pathway in ER-positive breast cancer and is associated with poor prognosis.
    Nair MG; Prabhu JS; Korlimarla A; Rajarajan S; P S H; Kaul R; Alexander A; Raghavan R; B S S; T S S
    Cancer Med; 2020 Aug; 9(15):5587-5597. PubMed ID: 32543775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA as biomarkers of canine mammary carcinoma in dogs.
    Fish EJ; Martinez-Romero EG; DeInnocentes P; Koehler JW; Prasad N; Smith AN; Bird RC
    J Vet Intern Med; 2020 May; 34(3):1282-1290. PubMed ID: 32342546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressions of miR-21 and miR-210 in Breast Cancer and Their Predictive Values for Prognosis.
    Wu X
    Iran J Public Health; 2020 Jan; 49(1):21-29. PubMed ID: 32309220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-modulating stromal components.
    Amini P; Nassiri S; Malbon A; Markkanen E
    Sci Rep; 2020 Mar; 10(1):5506. PubMed ID: 32218455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages.
    Sánchez-González I; Bobien A; Molnar C; Schmid S; Strotbek M; Boerries M; Busch H; Olayioye MA
    Cancer Res; 2020 Mar; 80(6):1330-1341. PubMed ID: 31911555
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.